2010 Annual Meeting

Session: Crystallization of Pharmaceutical and Biological Molecules 2: In Honor of the Late Dr. Jeff Wei of Eli Lilly

Additional session to cope with high rate of submissions.

Chair

Derek Griffin, Lilly Research Laboratories, Eli Lilly and Company

Co-Chair

Ryan C. Snyder, Bucknell University

Presentations

08:30 AM

Introductory Remarks

08:35 AM

(141a) A Streamlined Approach to Avoiding Oiling in Crystallization Processes of Api's and Intermediates

Mourad Hamedi, Micaela Caramellino, Kelvin Yong, Xiaoyong Fu

09:00 AM

(141b) Crystallization Development of a Pharmaceutical API through Implementation of Real-Time Supersaturation Feedback Control

James Vernille, Jose Tabora, Amanda Rogers, Jacob Albrecht, Richard D. Braatz, Mitsuko Fujiwara

09:15 AM

(141c) Designing a Reactive Crystallization Process for An Agglomerating API

Jennifer Kuehne-Willmore, Jeffrey Vicenzi, Sarah O'Keeffe, Douglas Kjell

09:35 AM

(141d) Use of a Crystallization Modifier to Enhance Impurity Rejection in the Crystallization of a Pharmaceutical Intermediate

Ann M. Czyzewski, Shuang Chen, Su Yu, Ian Marsden, Chen Ding, Calvin Becker, James J. Napier

09:55 AM

(141e) Crystallization Tendency of Amorphous Pharmaceuticals Prepared by Rapid Solvent Evaporation: Classification, Comparison with Undercooled Melts and Interpretation in Terms of Physico-Chemical Drug Compound Characteristics

Bernard Van Eerdenbrugh, Jared Baird, Lynne Taylor

10:15 AM

(141f) Spiral Growth Model for Organic Crystals of Real Complexity: How to Account for Non-Isotropic Behavior

Zubin B. Kuvadia, Michael F. Doherty

10:35 AM

(141g) Population Balance Modeling of Morphology Distribution of Asymmetric Crystals

Meenesh R. Singh, Jayanta Chakraborty, Doraiswami Ramkrishna